A practical reference on freeze-thaw: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-10-06. Anything still debated is marked as such rather than presented as settled.
Reconstitution is a critical handling step. The appropriate solvent—often sterile water, phosphate-buffered saline, or a water-acetonitrile mixture—is chosen based on peptide solubility. Adding solvent gently down the vial wall and swirling, rather than vortexing, reduces foaming and shear stress. The resulting solution should be clear; visible particles indicate incomplete dissolution or contamination. Concentration is recorded accurately because it affects subsequent use. If the peptide is not fully soluble, a small amount of organic solvent or a different buffer may be required, but this changes the final composition.
After reconstitution, solutions are divided into single-use aliquots and stored at -80°C. Labels include peptide name, concentration, buffer composition, date, and lot number. Freeze-thaw cycles are minimized by thawing only the needed aliquot on ice or at room temperature. Some peptides benefit from the addition of a carrier protein, such as bovine serum albumin, or a cryoprotectant like glycerol to reduce adsorption to plastic. Glass vials with low-binding surfaces are preferred for dilute solutions. Shipping of frozen aliquots uses dry ice and insulated containers to maintain the cold chain.
Receiving a peptide shipment requires immediate inspection of the packaging and temperature indicators. Any deviation from the specified cold chain should be documented and investigated. Upon arrival, solid peptides are generally kept at -20°C, whereas liquid formulations are stored at -80°C. Vials should be kept upright and protected from light. Repeated warming and cooling of the entire container is avoided by preparing smaller working aliquots. A log of lot numbers, receipt dates, and storage locations supports traceability and quality control.
After reconstitution, solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. Aliquots should be labeled with peptide identity, concentration, solvent, and date, then stored at the temperature specified by the supplier or protocol. Many peptides tolerate -20 °C for short periods, while -80 °C is preferred for longer storage. Frost-free freezers are generally avoided because temperature fluctuations can stress samples. Aseptic technique and sterile filters reduce microbial contamination, though filtration can also remove aggregated material or bind some peptides.
Peptide handling begins with careful receipt and inventory. Containers should be inspected for damage, label information should match the certificate of analysis, and storage location should be recorded. Many lyophilized peptides are electrostatic and may cling to vial walls or weighing paper, which can complicate transfer. Allowing a cold vial to equilibrate to room temperature before opening reduces condensation on the contents. Clean tools, gloves, and a low-humidity workspace limit contamination and moisture exposure during manipulation.
Reconstitution is the process of dissolving a dried peptide in a suitable solvent. The choice of solvent depends on solubility, charge, and sequence; sterile water is common, while buffers or small amounts of organic solvent may be needed for hydrophobic peptides. Adding solvent gently down the vial wall and mixing by inversion or gentle swirling reduces foaming and shear. Vortexing or vigorous pipetting can denature some peptides or promote aggregation. The resulting solution should be visually inspected for particles, turbidity, and complete dissolution before use.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (lyophilized) | -20°C | Stable for months to years; avoid frost-free freezers |
| Storage temperature (solution) | -80°C | Single-use aliquots preferred; avoid repeated freeze-thaw |
| Reconstitution solvent | Sterile water or buffer | Choice depends on peptide solubility and application |
| Container material | Glass or polypropylene | Low protein-binding surfaces reduce adsorption |
| Shipping condition | Dry ice | Insulated packaging maintains cold chain during transit |
After reconstitution, solutions are usually divided into single-use aliquots to limit repeated handling. Each aliquot is stored at a temperature appropriate for the peptide, with -20 °C or -80 °C common for longer-term laboratory storage. Freeze-thaw cycles are minimized because they can cause aggregation, precipitation, or loss of activity. Temperature monitoring and documented storage conditions support reproducibility across experiments. When a peptide is removed from storage, it is typically allowed to equilibrate before opening to reduce condensation.
Receiving a peptide begins with recording its identity, lot number, quantity, and arrival condition. Dry material is often kept in sealed containers with desiccant and an inert headspace to limit moisture and oxygen. Containers should be compatible with the peptide and solvent; some peptides adsorb to certain plastics or glass. Labels should include date, concentration, solvent, and storage location. A centralized inventory with temperature logs helps prevent loss and mix-ups.
Aliquoting reduces repeated temperature cycling for solutions and reconstituted samples. If a peptide is supplied as a powder, reconstitution usually involves adding a suitable solvent gently along the vial wall. Mixing by inversion or slow swirling is preferred over vortexing, which can create air-liquid interfaces that promote aggregation or foaming. The resulting solution should be inspected for clarity, particles, and color before storage. Labels on aliquots typically include concentration, solvent, date, and lot number, and open questions remain about the best solvent for every sequence.
Quality control relies on analytical methods that detect changes in purity, identity, and concentration. Reverse-phase high-performance liquid chromatography separates the parent peptide from degradation products, while mass spectrometry confirms molecular mass. Water content can be measured by Karl Fischer titration, and amino acid analysis or peptide mapping may reveal sequence-level modifications. Stability studies compare stored samples against baseline material at defined intervals. Documentation should link each result to a lot number, storage condition, and test date so that trends can be reviewed.
Receipt and inventory practices begin with inspection of packaging, temperature indicators, and lot-specific documentation. A certificate of analysis typically reports purity, identity, and sometimes residual water or counterion content. Containers should be labeled with the peptide name, lot number, date received, and storage location. Before a sealed vial is opened, it is often equilibrated to room temperature to reduce condensation on the contents. Clean tools, gloves, and a designated workspace limit contamination and accidental adsorption losses.
=== Medieval to early modern era === In medieval Europe, merchant guilds organized long-distance commerce and also participated in local wholesale trade. These guilds protected members, negotiated privileges, and in some places influenced city government and rules that shaped how goods were distributed and sold. In many regions, food distribution also relied on wholesale markets where trade concentrated in one place. Over time, wholesale markets became important for matching supply with demand and supporting price formation in urban food systems.
Despite the large differences in ingredient sourcing, studies have demonstrated that a plant-based diet can be just as edible and palatable as animal-based diets for dogs. There are now various commercial vegetarian and vegan diets available on the market.
Keyless entry system – a short-range handheld battery powered key fob transmitter, included with most modern cars, which can lock and unlock the doors of a vehicle from outside, eliminating the need to use a key. When a button is pressed, the transmitter sends a coded radio signal to a receiver in the vehicle, operating the locks. The fob must be close to the vehicle, typically within 5 to 20 meters. North America and Japan use a frequency of 315 MHz, while Europe uses 433.92 and 868 MHz. Some models can also remotely start the engine, to warm up the car. A security concern with all keyless entry systems is a replay attack, in which a thief uses a special receiver ("code grabber") to record the radio signal during opening, which can later be replayed to open the door. To prevent this, keyless systems use a rolling code system in which a pseudorandom number generator in the remote control generates a different random key each time it is used. To prevent thieves from simulating the pseudorandom generator to calculate the next key, the radio signal is also encrypted. Garage door opener – a short-range handheld transmitter which can open or close a building's electrically operated garage door from outside, so the owner can open the door upon arrival, and close it after departure. When a button is pressed the control transmits a coded FSK radio signal to a receiver in the opener, raising or lowering the door. Modern openers use 310, 315 or 390 MHz. To prevent a thief using a replay attack, modern openers use a rolling code system.
random walk A popular description of the path followed by a locomotive cell or particle when there is no bias in movement, i.e. when the direction of movement at any given instant is not influenced by the direction of movement in the preceding instant. The essential randomness of cell movement in a uniform environment is only apparent over long periods of time, however; in the short term, cells can and do exhibit a tendency to continue moving in the same direction.
=== Engineering === MHD is related to engineering problems such as plasma confinement, liquid-metal cooling in nuclear reactors, and electromagnetic casting. A magnetohydrodynamic drive, or MHD propulsor, is a method for propelling seagoing vessels using only electric and magnetic fields, with no moving parts. The working principle involves electrifying the propellant (gas or water), which can then be directed by a magnetic field, thereby pushing the vehicle in the opposite direction. Although some working prototypes exist, MHD drives remain impractical. The first prototype of this type of propulsion was built and tested in 1965 by Steward Way, a professor of mechanical engineering at the University of California, Santa Barbara. While on leave from his job at Westinghouse Electric, Way assigned his senior-year undergraduate students to develop a submarine using this new propulsion system. In the early 1990s, the Ship & Ocean Foundation (Minato-ku, Tokyo) built an experimental boat, the Yamato-1, which used a magnetohydrodynamic drive incorporating a superconductor cooled by liquid helium and could travel at 15 km/h. MHD power generation fueled by potassium-seeded coal-combustion gas showed potential for more efficient energy conversion (the absence of solid moving parts allows operation at higher temperatures) but ultimately failed due to cost-prohibitive technical difficulties. One major engineering problem was the abrasion-induced failure of the wall of the primary-coal combustion chamber.
Sources: en.wikipedia.org
=== 4 June === One person was killed in a Russian attack in Kherson Oblast. Another was killed by shelling in Sumy Oblast. The SBU arrested a man in Zaporizhzhia Oblast on suspicion of plotting an attack against a military enlistment office on behalf of Russia. Russia "vehemently denied" any involvement in an event in which five coffins draped in French flags were placed under the Eiffel Tower in Paris with the inscription "French soldiers of Ukraine". French media claimed that it was a Kremlin attempt to weaken French support for Ukraine. Ukraine announced plans to establish a "decentralised energy system" using "mini-power plants" to reduce vulnerability to Russian attacks after the country's generating capacity was found to have been reduced to below 20 gigawatts from its previous capacity of 55 gigawatts.
== History == In 1994 Tsutomu Nomizu and colleagues at Nagoya University performed the first mass spectrometry experiments of single cells. Nomizu realized that single cells could be nebulized, dried, and ignited in plasma to generate clouds of ions which could be detected by emission spectrometry. In this type of experiment elements such as calcium within the cell could be quantified. Inspired by Flow cytometry, in 2007 Scott D. Tanner built upon this ICP-MS with the first multiplexed assay using lanthanide metals to label DNA and cell surface markers. In 2008 Tanner described the tandem attachment of a flow cytometer to an ICP-MS instrument as well as new antibody tags that would allow massively multiplexed analysis of cell markers. By further optimizing the detection speed and sensitivity of this flow coupled to ICP-MS they built the first CyTOF instrument. The CyTOF instrument was originally owned by the Canadian company DVS Sciences but is now the exclusive product of Fluidigm after their acquisition in 2014 of DVS sciences. In 2022 Fluidigm received a capital infusion and changed its name to Standard BioTools. There have been 4 iterations of the CyTOF apparatus named CyTOF, CyTOF2, Helios™ and CyTOF XT. The successive improvements were largely in increased detection range and software parameters with the Helios instrument able to detect from metals ranging from yttrium-89 to bismuth-209 and throughput and analyze 2000 events per minute.
McCoy warned that, if China's numerous breaches on Taiwan become "a crippling embargo of Taiwan", the US would lose Taiwan, risking a break of "America's island chain in the Pacific littoral, pushing it back to a 'second island chain' in the mid-Pacific", regardless of the US's decisions on Taiwan. He further cited growing anti-American sentiment in the Philippines, the opposition toward AUKUS (trilateral security partnership between Australia, the United Kingdom, and the United States) from certain members of the Labor Party as a threat to Australia's sovereignty, and the Republican Party populism in the US under Trump (or his successor-in-line JD Vance) potentially curtailing the US's ability to maintain its alliance with the Asia-Pacific countries. In January 2025, almost two weeks before Biden ended his term, Hoover Institution senior fellow Niall Ferguson wrote that the US has had "a second cold war" with China for at least six years and that the war further intensified under the Biden administration. Ferguson drew comparisons between Trump and then-US president Ronald Reagan, like assassination attempts on them, but further suggested that Trump use the Reagan administration's past approach in foreign policy.
=== The Human Chimera Prohibition Act === On 11 July 2005, a bill known as The Human Chimera Prohibition Act was introduced into the United States Congress by Senator Samuel Brownback; however, it died in Congress sometime in the next year. The bill was introduced based on findings that science had progressed to the point where human and nonhuman species could be merged to create new forms of life. Because of this, ethical issues might arise as the line blurred between humans and other animals, and according to the bill with this blurring of lines would come a show of disrespect for human dignity. The final claim brought up in The Human Chimera Prohibition Act was that there was an increasing amount of zoonotic diseases, and that the creation of human-animal chimeras might allow these diseases to reach humans. On 22 August 2016, another bill, The Human-Animal Chimera Prohibition Act of 2016, was introduced to the United States House of Representatives by Christopher H. Smith. It identified a human-animal chimera as:
Cross-matching or crossmatching is a test performed before a blood transfusion as part of blood compatibility testing. Normally, this involves adding the recipient's blood plasma to a sample of the donor's red blood cells. If the blood is incompatible, the antibodies in the recipient's plasma will bind to antigens on the donor red blood cells. This antibody-antigen reaction can be detected through visible clumping or destruction of the red blood cells, or by reaction with anti-human globulin. Along with blood typing of the donor and recipient and screening for unexpected blood group antibodies, cross-matching is one of a series of steps in pre-transfusion testing. In some circumstances, an electronic cross-match can be performed by comparing records of the recipient's ABO and Rh blood type against that of the donor sample. In emergencies, blood may be issued before cross-matching is complete. Cross-matching is also used to determine compatibility between a donor and recipient in solid organ transplantation including heart/lung transplation.
Sources: en.wikipedia.org
Common solvents include sterile water, phosphate-buffered saline, and water-acetonitrile mixtures. The choice depends on the peptide's solubility profile and the buffer compatibility for the intended application. Manufacturers often provide a recommended solvent on the product information sheet.
Solutions are typically stored at -80°C in single-use aliquots to avoid repeated freeze-thaw cycles. They should be protected from light and kept in low-binding containers. Some peptides require a carrier protein or cryoprotectant to prevent adsorption and aggregation.
Records should include the lot number, date received, storage temperature, and any handling steps. A log of freeze-thaw cycles and aliquot preparation helps track stability. This documentation supports traceability and quality control.
It should first equilibrate to room temperature in a sealed container to prevent condensation on the cold contents. Opening too soon can introduce moisture and reduce stability, and the waiting period depends on vial size and packaging.